GPT and metabolic syndrome: The improvement of liver markers (AST, ALT), even in the absence of correlation with the percentage concentrations of AM, and the negative correlation of GGT, a marker for hepatobiliary diseases and metabolic syndrome, suggest the reduction of oxidative stress in MASLD.